From: The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?
Clinical characteristic | Case (n) | Expression intensity (%) | P value | |
---|---|---|---|---|
Gender | Male | 137 | 3.03 ± 3.274 | 0.484 |
Female | 434 | 3.27 ± 3.526 | ||
Age | < 45 years | 236 | 3.29 ± 3.341 | 0.652 |
≥ 45 years | 335 | 3.16 ± 3.555 | ||
TGAb | ≤ 115 IU/mL | 456 | 3.00 ± 3.373 | 0.005 |
> 115 IU/mL | 115 | 4.03 ± 3.717 | ||
TPOAb | ≤ 34 IU/mL | 476 | 3.09 ± 3.477 | 0.042 |
> 34 IU/mL | 95 | 3.91 ± 3.362 | ||
TSH | ≤ 4 uIU/ml | 456 | 3.16 ± 3.399 | 0.511 |
> 4 uIU/ml | 115 | 3.40 ± 3.767 | ||
Tumour size | < 1 cm | 330 | 2.93 ± 3.034 | 0.032 |
≥ 1 cm | 241 | 3.59 ± 3.957 | ||
Multifocality | Yes | 172 | 3.53 ± 3.603 | 0.133 |
No | 399 | 3.06 ± 3.379 | ||
Extrathyroidal extension | Yes | 159 | 3.90 ± 1.977 | 0.653 |
No | 412 | 3.56 ± 3.186 | ||
Lymph node metastasis | Yes | 213 | 3.54 ± 4.124 | 0.075 |
No | 358 | 3.01 ± 2.996 | ||
Thyroiditis | Yes | 99 | 4.21 ± 3.942 | 0.005 |
No | 471 | 2.99 ± 3.322 |